No Data
Arvinas Is Maintained at Overweight by Wells Fargo
Arvinas Is Maintained at Overweight by Wells Fargo
Express News | Arvinas Inc : Wells Fargo Cuts Target Price to $60 From $63
Buy Rating Affirmed on Arvinas With Promising Trial Updates and Robust Financial Outlook
Arvinas, Inc. (NASDAQ:ARVN) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Arvinas, Inc. (NASDAQ:ARVN) last week reported its latest first-quarter results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations.
Analysts Offer Insights on Healthcare Companies: Inogen (INGN), Arvinas Holding Company (ARVN) and UniQure (QURE)
Arvinas Price Target Maintained With a $57.00/Share by Wedbush
Arvinas Price Target Maintained With a $57.00/Share by Wedbush